Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | International Symposium on Acute Leukemias: key messages from the 2019 meeting

Wolfgang Hiddemann • 15 Mar 2019
ISAL 2019
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia

Chair of the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, Wolfgang Hiddemann, MD, PhD, of LMU Hospital Munich, Munich, Germany, discusses the highlights of this year’s meeting, with many updates, particularly in acute myeloid leukemia, since the last meeting in 2017.

More from Wolfgang Hiddemann

3:08
ISAL 2023: looking forward to this year's meeting and insights into the program
Wolfgang Hiddemann • 16 Mar 2023
1:04
Acute leukemia research at LMU Munich
Wolfgang Hiddemann • 14 Mar 2019
8:26
Challenging the norms for elderly AML treatment: clinical trials & intensive therapy
Alan Burnett et al. • 17 Feb 2018
11:35
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission therapy
Alan Burnett et al. • 2 Mar 2018

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals